1. Using semaglutide in T2D with CKD, including PBS access
You know the patient. Their eGFR is sliding the wrong way, and now they're asking about the jab their neighbour swears by.
In The Medical Republic, endocrinologist Dr Ramy Bishay reviews the trial evidence for semaglutide in type 2 diabetes with CKD. He covers blood sugar control plus kidney and heart outcomes.
He also covers PBS access, which is fair. Picking the drug is the easy bit. Getting it subsidised is where the 15-minute consult goes to die.
The takeaway: Read Bishay's piece before your next diabetic CKD patient asks about semaglutide.